Dusa Pharmaceuticals, Inc.

MA · United States · Reporting entity ID 100000011054

Total reported 2019–2025

$258K

#1,830 of 2,960 reporting companies — 0% of all reported industry payments

$249K in general payments across 3,162 records, plus $9K in research funding across 1 records.

How it breaks down

General payments $249,028

Research funding $9,369

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.